Learn Before
Concept
Coronavirus 2019 and People Living With Human Immunodeficiency Virus: Outcomes for Hospitalized Patients in New York City
- This study details the outcomes of persons living with HIV and COVID-19 in the New York City healthcare system
- Persons involved with the study were identified through positive COVID-19 tests from 5 hospitals local to New York City
- 2% of patients, or 88 individuals, hospitalized with COVID-19 were persons with HIV
- Most individuals were of Black or Hispanic descent
- Most patients (58%) with both COVID-19 and HIV were assessed to have a CD4 level of less than 200 cells/mm³ upon admission
- Recovery time of patients with HIV was seen to be only slightly faster than those without which may be attributed to regular usage of antiviral drugs
- Overall, the conditions of most patients with comorbid HIV and COVID-19 who also had their HIV under control with antivirals had similar rates of death, continued hospitalization, and hospital discharge
- However, patients with HIV due to organ transplantation saw significantly higher rates of mortality
0
1
Updated 2020-08-25
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
COVID-19 in patients with HIV: clinical case series
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy
Coronavirus 2019 and People Living With Human Immunodeficiency Virus: Outcomes for Hospitalized Patients in New York City
COVID-19 pneumonia in an HIV-positive woman on antiretroviral therapy and undetectable viral load in Porto Alegre, Brazil – Case Study
Analysis of type I IFN response and T cell activation in severe COVID-19/HIV-1 coinfection - United States